These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20722389)

  • 1. Trichohyalin is a potential major autoantigen in human alopecia areata.
    Leung MC; Sutton CW; Fenton DA; Tobin DJ
    J Proteome Res; 2010 Oct; 9(10):5153-63. PubMed ID: 20722389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair follicle structures targeted by antibodies in patients with alopecia areata.
    Tobin DJ; Hann SK; Song MS; Bystryn JC
    Arch Dermatol; 1997 Jan; 133(1):57-61. PubMed ID: 9006373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
    Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine alopecia areata autoantibodies target multiple hair follicle antigens and may alter hair growth. A preliminary study.
    Tobin DJ; Alhaidari Z; Olivry T
    Exp Dermatol; 1998 Oct; 7(5):289-97. PubMed ID: 9832317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural canine homologue of alopecia areata in humans.
    Tobin DJ; Gardner SH; Luther PB; Dunston SM; Lindsey NJ; Olivry T
    Br J Dermatol; 2003 Nov; 149(5):938-50. PubMed ID: 14632797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response.
    Tobin DJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):176-81. PubMed ID: 14582669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DEBR rat, alopecia areata and autoantibodies to the hair follicle.
    McElwee KJ; Pickett P; Oliver RF
    Br J Dermatol; 1996 Jan; 134(1):55-63. PubMed ID: 8745887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased retinol-binding protein (RBP) 4 and anti-RBP4 antibody in alopecia areata.
    Ahn KJ; Choi EA; Kim J; Lee JH; Lee KH; Bang D; Cho SB
    Br J Dermatol; 2011 Oct; 165(4):837-44. PubMed ID: 21711327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Autoantigen Epitopes in Alopecia Areata.
    Wang EHC; Yu M; Breitkopf T; Akhoundsadegh N; Wang X; Shi FT; Leung G; Dutz JP; Shapiro J; McElwee KJ
    J Invest Dermatol; 2016 Aug; 136(8):1617-1626. PubMed ID: 27094591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
    Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
    J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
    McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
    Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications.
    Jadeja SD; Tobin DJ
    Front Immunol; 2022; 13():890027. PubMed ID: 35720384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
    Paus R; Slominski A; Czarnetzki BM
    Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 interferon signature in the scalp lesions of alopecia areata.
    Ghoreishi M; Martinka M; Dutz JP
    Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling.
    Dobreva A; Paus R; Cogan NG
    Math Med Biol; 2018 Sep; 35(3):387-407. PubMed ID: 28992198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair follicle is a target of stress hormone and autoimmune reactions.
    Ito T
    J Dermatol Sci; 2010 Nov; 60(2):67-73. PubMed ID: 20943348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse.
    Bertolini M; Pretzlaff M; Sulk M; Bähr M; Gherardini J; Uchida Y; Reibelt M; Kinori M; Rossi A; Bíró T; Paus R
    Br J Dermatol; 2016 Sep; 175(3):531-41. PubMed ID: 27059672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.